Verition Fund Management
LUCD icon

Verition Fund Management’s Lucid Diagnostics LUCD Stock Holding History

Verition Fund Management’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$694K Buy
+103,700
New +$112K ﹤0.01% 1559

Other funds holding LUCD

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Verition Fund Management's LUCD Position: Q4 2024 in Review

Verition Fund Management sold out of Lucid Diagnostics (LUCD) in Q4 2024, closing a stake of 39,711 shares — an estimated $32.4K sold.

Verition Fund Management first reported a position in LUCD in Q1 2022 and held it in 11 quarters. The position peaked at $122K in Q1 2022. 33 funds tracked by Wall St. Rank hold LUCD as of Q4 2024.

  • Verition Fund Management reported no remaining Lucid Diagnostics position as of Q4 2024 after selling out during the quarter.
  • Verition Fund Management sold 39,711 Lucid Diagnostics shares in Q4 2024, an estimated $32.4K.
  • Verition Fund Management first reported a position in Lucid Diagnostics in Q1 2022 and held it in 11 quarters.
  • Verition Fund Management's Lucid Diagnostics position peaked at $122K in Q1 2022.
  • 33 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q4 2024.

Based on Verition Fund Management's 13F filing for Q4 2024, filed 14 Feb 2025.